250
Participants
Start Date
January 31, 2017
Primary Completion Date
October 31, 2018
Study Completion Date
January 31, 2019
GastroPanel test
Dyspeptic patients will be referred for the GastroPanel test, containing four biomarkers specific for the gastric mucosa: 1) Pepsinogen I (P-PGI), 2) Pepsinogen II (P-PGII), 3) Gastrin-17 (P-G-17) and 4) H. pylori antibody (P-HpAb).
Gastroscopy
Dyspeptic patients will undergo gastroscopy examination, with targeted biopsies from the antrum and corpus, following the protocol of the OLGA classification for chronic gastritis and Sydney Classification.
RECRUITING
Homerton University Hospital, London
Lead Sponsor
Biohit Healthcare Ltd
INDUSTRY